DE69728420D1 - Methoden zur behandlung von durch chlamydia pneumoniae verursachten herzkrankheiten - Google Patents

Methoden zur behandlung von durch chlamydia pneumoniae verursachten herzkrankheiten

Info

Publication number
DE69728420D1
DE69728420D1 DE69728420T DE69728420T DE69728420D1 DE 69728420 D1 DE69728420 D1 DE 69728420D1 DE 69728420 T DE69728420 T DE 69728420T DE 69728420 T DE69728420 T DE 69728420T DE 69728420 D1 DE69728420 D1 DE 69728420D1
Authority
DE
Germany
Prior art keywords
methods
heart diseases
chlamydia pneumoniae
treating chlamydia
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69728420T
Other languages
English (en)
Other versions
DE69728420T2 (de
Inventor
Sandeep Gupta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of DE69728420D1 publication Critical patent/DE69728420D1/de
Application granted granted Critical
Publication of DE69728420T2 publication Critical patent/DE69728420T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DE69728420T 1996-10-18 1997-10-17 Methoden zur behandlung von durch chlamydia pneumoniae verursachten herzkrankheiten Expired - Lifetime DE69728420T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2869396P 1996-10-18 1996-10-18
GBGB9621771.6A GB9621771D0 (en) 1996-10-18 1996-10-18 Method of treatment of heart disease
GB9621771 1996-10-18
PCT/GB1997/002862 WO1998017280A1 (en) 1996-10-18 1997-10-17 Method of treatment of heart disease caused by chlamydia pneumoniae

Publications (2)

Publication Number Publication Date
DE69728420D1 true DE69728420D1 (de) 2004-05-06
DE69728420T2 DE69728420T2 (de) 2004-12-30

Family

ID=26310252

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69728420T Expired - Lifetime DE69728420T2 (de) 1996-10-18 1997-10-17 Methoden zur behandlung von durch chlamydia pneumoniae verursachten herzkrankheiten

Country Status (13)

Country Link
US (1) US6281199B1 (de)
EP (1) EP0952835B1 (de)
JP (1) JP3580829B2 (de)
AT (1) ATE262910T1 (de)
AU (1) AU736983B2 (de)
CA (1) CA2269054C (de)
DE (1) DE69728420T2 (de)
DK (1) DK0952835T3 (de)
ES (1) ES2218665T3 (de)
GB (1) GB9621771D0 (de)
NZ (1) NZ335825A (de)
PT (1) PT952835E (de)
WO (1) WO1998017280A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6710033B1 (en) 1996-08-14 2004-03-23 Vanderbilt University Methods and treatment of multiple sclerosis
US6890526B2 (en) 1997-05-06 2005-05-10 Vanderbilt University Methods and reagents for the treatment of multiple sclerosis
FR2771008B1 (fr) * 1997-11-17 2000-04-28 Hoechst Marion Roussel Inc Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
US6861411B1 (en) 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
FR2791436B1 (fr) * 1999-03-23 2001-06-15 Inst Nat Sante Rech Med Methode de determination d'une predisposition a une maladie tromboembolique veineuse et utilisation d'agents actifs sur les chlamydia pour la prevention et/ou le traitement de cette maladie
US7056893B2 (en) 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US6239113B1 (en) 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
IL133038A0 (en) * 1999-11-18 2001-03-19 Savyon Diagnostics Ltd Novel diagnosis and treatment for atherosclerosis
KR20010069066A (ko) 2000-01-12 2001-07-23 이종원 저산소 농도하에서 생존이 가능하도록 하는 동물세포의배양방법
US6914051B1 (en) * 2000-06-28 2005-07-05 David M Allen Penetrating antibiotic gel for soft tissue diseases
DE60135843D1 (de) * 2000-07-03 2008-10-30 Maria De Lourdes Higuchi Prävention und behandlung von mycoplasma-assoziierten krankheiten mit trans-sialidase und/oder neuraminidase
US7335638B2 (en) * 2000-07-03 2008-02-26 Maria De Lourdes Higuchi Prevention and treatment of mycoplasma-associated diseases
US7148028B2 (en) * 2001-08-22 2006-12-12 Cambridge Theranostics Ltd. Methods and means relating to atherosclerosis
US20040077533A1 (en) * 2002-05-23 2004-04-22 Sayada Chalom B. Methods and compositions for treating bacterial infections and diseases associated therewith
US20090149453A1 (en) * 2002-05-23 2009-06-11 Activbiotics Pharma Llc Methods and compositions for treating bacterial infections and diseases associated therewith
CA2490062A1 (en) * 2002-05-23 2003-12-04 Activbiotics, Inc. Methods of treating bacterial infections and diseases associated therewith
WO2004009084A1 (en) * 2002-07-18 2004-01-29 Pfizer Products Inc. Methods of treating infection using antibiotics and glycogen phosphorylase inhibitors
AU2003296963A1 (en) * 2002-12-12 2004-07-09 Activbiotics, Inc. Methods and compositions for treating and preventing ear infections
WO2004054548A1 (en) * 2002-12-12 2004-07-01 Activbiotics,Inc. Method and reagents for treating or preventing atherosclerosis and diseases associated therewith
BRPI1004987A2 (pt) 2010-11-26 2013-03-26 Maria De Lourdes Higuchi prevenÇço e tratamento de doenÇas associadas as micoplasma
US7732410B2 (en) * 2003-03-28 2010-06-08 Higuchi Maria De Lourdes Compositions for inhibiting atherosclerosis
US7674832B2 (en) * 2003-03-28 2010-03-09 Higuchi Maria De Lourdes Compositions for promoting wound healing and treating psoriasis
US8822232B2 (en) 2003-03-28 2014-09-02 Maria De Lourdes Higuchi Diagnosis, prevention and treatment of disorders characterized by undesirable cell proliferation
JP2004323414A (ja) * 2003-04-24 2004-11-18 Japan Science & Technology Agency １４員環マクロライド化合物を利用した、血管平滑筋の増殖に起因する疾患治療剤
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
WO2014099323A1 (en) * 2012-12-17 2014-06-26 Cormatrix Cardiovascular, Inc. Intra-myocardial agent delivery device, system and method
US11660269B2 (en) * 2019-03-29 2023-05-30 University Of Kentucky Research Foundation Liposomal compounds and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4427782A (en) 1981-03-03 1984-01-24 Caldwell Harlan D Isolation of principal outer membrane protein and antigen of Chlamydia trachomatis
DE3650571T2 (de) 1985-01-14 1997-02-27 Chiron Corp Hauptprotein der Aussenmembran von Chlamydia
FI883067A (fi) 1988-06-27 1989-12-28 Labsystems Oy Foerfarande foer behandling av koronarkaerlsjukdom.
US5424187A (en) * 1991-06-14 1995-06-13 Board Of Regents Of The University Of Washington Method of screening for arterial chlamydial granuloma

Also Published As

Publication number Publication date
AU4712697A (en) 1998-05-15
DK0952835T3 (da) 2004-08-02
US6281199B1 (en) 2001-08-28
WO1998017280A1 (en) 1998-04-30
EP0952835B1 (de) 2004-03-31
GB9621771D0 (en) 1996-12-11
CA2269054A1 (en) 1998-04-30
JP3580829B2 (ja) 2004-10-27
CA2269054C (en) 2005-05-03
DE69728420T2 (de) 2004-12-30
ES2218665T3 (es) 2004-11-16
NZ335825A (en) 2001-01-26
EP0952835A1 (de) 1999-11-03
ATE262910T1 (de) 2004-04-15
AU736983B2 (en) 2001-08-09
JP2002508738A (ja) 2002-03-19
PT952835E (pt) 2004-08-31

Similar Documents

Publication Publication Date Title
DE69728420D1 (de) Methoden zur behandlung von durch chlamydia pneumoniae verursachten herzkrankheiten
BR9610838A (pt) Processo para tratar um indivìduo tendo uma condição patológica envolvendo neovascularização.
TR199900083T2 (xx) Klaritromisinin kristal bi�imi I.
EA199901016A1 (ru) 9-оксим-производные эритромицина
PT966447E (pt) Moleculas pequenas uteis no tratamento de doencas inflamatorias
BR9714287A (pt) Antibiótico cristalino designado solvato 6-o-metileritromicina forma 0, solvato de 6-o-metileritromicina forma 0, composição, processos para tratamento de infecções bacterianas em um mamìfero hospedeiro com necessidade de tal tratamento e para preparação de solvato de 6-o-metileritomicina a forma 0, 6-o-metileritromicina forma 0--etanolato, suspensão para administração oral, e, complexo de solvato de 6-o-metileritromicina a forma 0-carbÈmero.
NZ524888A (en) Nucleic acids and proteins from streptococcus groups A & B
DE69636228D1 (de) Therapeutische Zusammensetzungen zur Behandlung von Lawsonia intracellularis Infektionen
DE59004337D1 (de) Sterole, deren fettsäureester und glucoside; verfahren zu ihrer herstellung; spontan dispergierbare mittel mit diesen verbindungen, sowie ihre verwendung zur behandlung von tumoren.
BR9510423A (pt) Formulação lipossomal multilamelar de baixa rigidez processo de tratamento ou de profilaxia de uma infecção bacteriana em um animal e de uma variante mucoìde da mesma, uso da formulação lipossomal antibacteriana
PT1042340E (pt) Oxima de 6-o-alquil-eritromicina b
DE69831000D1 (de) Verwendung von cytidin und cytosin-enthaltenden verbindungen zur behandlung von reizmittelgelgebrauch
NO20001439L (no) 3'-N-modifiserte 6-O-substituerte erytromycin ketolid- derivater med antibakteriell aktivitet
HUP0004282A2 (hu) 2-Halogén-6-0-szubsztituált ketolidszármazékok
BR0101090A (pt) Composição para administração parenteral, e, método para prevenção ou tratamento de infecções ou infestações por helmintos, acarìdeos ou artrópodo endo- ou ectoparasìticos em um animal de sangue quente
PT932613E (pt) Expressao de bloqueio de factoes de virulencia em s. aureus
DK1007530T3 (da) 6-O-substituerede erythromycinforbindelser samt fremgangsmåde til fremstilling heraf
DE69717988D1 (de) Topische verabreichung von premafloxacin zur behandlung von systemischen bakteriellen erkrankungen
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
MY133360A (en) Diphosphate salt of a "4" -substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition
MX9803694A (es) Derivados de 3-desoxi-3-desclandinosa de eritromicinas a y b.
NO981594L (no) Behandling av infeksjoner forÕrsaket av Helicobacter pylori
HUT46075A (en) Process for producing new macrolid antibiotic and pharmaceutics comprising the new antibiotic
RU95111956A (ru) Способ лечения запущенных форм рака

Legal Events

Date Code Title Description
8364 No opposition during term of opposition